AHA policy recommendations to House Ways and Means Committee leaders as they begin developing Medicare-related legislation to address the opioid crisis. The committee is seeking feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. AHA also has submitted recommendations to other committees of jurisdiction, as Congress plans to enact comprehensive legislation on opioids this spring.
AHA comments to the House Subcommittee on Health Energy and Commerce on bills related to the opioid crisis.
As the nation continues to struggle with the devastating public health crisis created by the opioid epidemic, it is encouraging to see the Committe
Special Bulletin: CMS Finalizes Policy and Technical Changes to the Medicare Advantage and Part D Prescription Drug Programs
The CMS on April 6 finalized a rule that will update the Medicare Advantage and Part D prescription drug programs for contract year 2019.
AHA reiterates support for legislation to align 42 CFR Part 2 with HIPAA.
Legislative Advisory: Provisions Addressing The Opioid Epidemic in the FY 2018 Consolidated Appropriations Act
Update on Key Issues in the Behavioral Health Care Field: April 2018